Structure–activity relationships of bifunctional cyclic disulfide peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors

[1]  V. Hruby,et al.  Structure-activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors. , 2006, Journal of medicinal chemistry.

[2]  M. Heinricher,et al.  Neural basis for the hyperalgesic action of cholecystokinin in the rostral ventromedial medulla. , 2004, Journal of neurophysiology.

[3]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[4]  T. Hökfelt,et al.  The role of spinal cholecystokinin in chronic pain states. , 2002, Pharmacology & toxicology.

[5]  F. Albericio,et al.  Practical protocols for stepwise solid-phase synthesis of cysteine-containing peptides. , 2002, The journal of peptide research : official journal of the American Peptide Society.

[6]  A. D'Ursi,et al.  Environmental mimic of receptor interaction: conformational analysis of CCK-15 in solution. , 2002, Journal of medicinal chemistry.

[7]  T. Vanderah,et al.  Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin , 2001, Pain.

[8]  J. Crawley,et al.  International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. , 1999, Pharmacological reviews.

[9]  T. Hökfelt,et al.  Cholecystokinin/opioid interactions , 1999, Brain Research.

[10]  M. Pellegrini,et al.  Molecular complex of cholecystokinin-8 and N-terminus of the cholecystokinin A receptor by NMR spectroscopy. , 1999, Biochemistry.

[11]  B. Roques,et al.  CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology , 1999, Progress in Neurobiology.

[12]  V. Hruby,et al.  Cyclic enkephalin analogs that are hybrids of DPDPE-related peptides and metenkephalin-Arg-Gly-Leu: prohormone analogs that retain good potency and selectivity for delta opioid receptors. , 1999, The journal of peptide research : official journal of the American Peptide Society.

[13]  V. Hruby,et al.  Conformation-activity relationships of opioid peptides with selective activities at opioid receptors. , 1999, Biopolymers.

[14]  V. Hruby,et al.  Cyclic enkephalin analogues with exceptional potency and selectivity for δ-opioid receptors , 1997 .

[15]  M. Chorev,et al.  Conformational studies of RS-66271, an analog of parathyroid hormone-related protein with pronounced bone anabolic activity. , 1997, Journal of medicinal chemistry.

[16]  V. Hruby,et al.  Cyclic enkephalin analogues with exceptional potency and selectivity for delta-opioid receptors. , 1997, Journal of medicinal chemistry.

[17]  V. Hruby,et al.  Conformational analysis of beta-methyl-para-nitrophenylalanine stereoisomers of cyclo[D-Pen2, D-Pen5]enkephalin by NMR spectroscopy and conformational energy calculations. , 1998, Biopolymers.

[18]  V. Hruby,et al.  The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptor , 1996, Journal of medicinal chemistry.

[19]  Xiao-jun Xu,et al.  The role of cholecystokinin in nociception, neuropathic pain and opiate tolerance , 1996, Regulatory Peptides.

[20]  R. Horváth,et al.  Probing the Stereochemical Requirements for Receptor Recognition of δ Opioid Agonists through Topographic Modifications in Position 1 , 1996 .

[21]  V. Hruby,et al.  Enkephalin analog prodrugs: assessment of in vitro conversion, enzyme cleavage characterization and blood-brain barrier permeability. , 1996, The Journal of pharmacology and experimental therapeutics.

[22]  C. George,et al.  Conformational Determinants of Agonist versus Antagonist Properties of [d-Pen2,d-Pen5]Enkephalin (DPDPE) Analogs at Opioid Receptors. Comparison of X-ray Crystallographic Structure, Solution 1H NMR Data, and Molecular Dynamic Simulations of [l-Ala3]DPDPE and [d-Ala3]DPDPE , 1996 .

[23]  V. Hruby,et al.  Conformational properties of the unnatural amino acid β-methylphenylalanine in a linear octapeptide system ; correlations of 13C-NMR chemical shifts with the side-chain stereochemistry of these amino acid residues , 1994 .

[24]  Xiao-jun Xu,et al.  Cholecystokinin and morphine analgesia: variations on a theme. , 1994, Trends in pharmacological sciences.

[25]  V. Hruby,et al.  optymization of disulfidel bont formation , 1994 .

[26]  V. Hruby,et al.  Conformational analysis of four β‐methylphenylalanine stereoisomers in a bioactive peptide by z‐filtered relay NMR spectroscopy , 1993 .

[27]  V. Hruby,et al.  Models for the A- and B-receptor-bound conformations of CCK-8. , 1993, Biochemical and biophysical research communications.

[28]  E. Giralt,et al.  Cyclization of disulfide-containing peptides in solid-phase synthesis. , 2009, International journal of peptide and protein research.

[29]  V. Hruby,et al.  Topographically designed analogues of [D-Pen,D-Pen5]enkephalin. , 1991, Journal of medicinal chemistry.

[30]  V. Hruby,et al.  Highly potent and selective cholecystokinin analogues for the CCK-B receptor , 1991 .

[31]  P. Schiller,et al.  Enkephalin analogues containing β‐naphthylalanine at the fourth position , 1990 .

[32]  Gordon M. Crippen,et al.  Combined use of stereospecific deuteration, NMR, distance geometry, and energy minimization for the conformational analysis of the highly .delta. opioid receptor selective peptide [D-Pen2,D-Pen5]enkephalin , 1990 .

[33]  B. Roques,et al.  Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors. , 1989, Journal of medicinal chemistry.

[34]  M. Karplus,et al.  Conformational Properties of the Delta Opioid Peptide Cyclic(D-Pen2,D-Pen5)enkephalin in Aqueous Solution Determined by NMR and Energy Minimization Calculations. , 1988 .

[35]  B. Montgomery Pettitt,et al.  The conformational properties of the delta opioid peptide [D-Pen2,D-Pen5]enkephalin in aqueous solution determined by NMR and energy minimization calculations , 1988 .

[36]  B. Roques,et al.  Cyclic cholecystokinin analogues with high selectivity for central receptors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Schwyzer.  Molecular mechanism of opioid receptor selection. , 1986, Biochemistry.

[38]  B. Roques,et al.  Conformational analysis of cholecystokinin CCK26-33 and related fragments by 1H NMR spectroscopy, fluorescence-transfer measurements, and calculations. , 1986, Biochemistry.

[39]  Ad Bax,et al.  MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy , 1985 .

[40]  L. Watkins,et al.  Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates , 1985, Brain Research.

[41]  H. Mosberg,et al.  1H n.m.r. investigation of conformational features of cyclic enkephalinamide analogs. , 2009, International journal of peptide and protein research.

[42]  T F Burks,et al.  Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[43]  V. Hruby,et al.  Conformationally constrained cyclic enkephalin analogs with pronounced delta opioid receptor agonist selectivity. , 1983, Life sciences.

[44]  L. Watkins,et al.  Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. , 1983, Science.

[45]  C. Altona,et al.  Component vicinal coupling constants for calculating side-chain conformations in amino acids. , 2009, International journal of peptide and protein research.

[46]  M. Marraud,et al.  Conformational dependence of the vicinal proton coupling constant for the CαCβ bond in peptides , 1982 .

[47]  J. DiMaio,et al.  Cyclic enkephalin analogs containing a cystine bridge. , 1981, Biochemical and biophysical research communications.

[48]  Richard R. Ernst,et al.  Investigation of exchange processes by two‐dimensional NMR spectroscopy , 1979 .

[49]  P. Schiller,et al.  Determination of the intramolecular tyrosine-tryptophan distance in a 7-peptide related to the C-terminal sequence of cholecystokinin. , 2009, International journal of peptide and protein research.

[50]  B. Morgan,et al.  Structure‐activity relationships of methionine‐enkephalin , 1976, The Journal of pharmacy and pharmacology.

[51]  F. Cardinaux,et al.  Evidence for analgesic activity of enkephalin in the mouse , 1976, Nature.

[52]  K. Pachler.  Nuclear magnetic resonance study of some α-amino acids—II. Rotational isomerism , 1964 .

[53]  K. Pachler.  Nuclear magnetic resonance study of some α-amino acids—I: Coupling constants in alkaline and acidic medium , 1963 .